NBC Securities Inc. Acquires 128 Shares of IQVIA Holdings Inc. (NYSE:IQV)

NBC Securities Inc. boosted its holdings in IQVIA Holdings Inc. (NYSE:IQV) by 4.6% during the first quarter, HoldingsChannel.com reports. The fund owned 2,919 shares of the medical research company’s stock after purchasing an additional 128 shares during the period. NBC Securities Inc.’s holdings in IQVIA were worth $738,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in IQV. Jag Capital Management LLC raised its holdings in shares of IQVIA by 0.4% during the fourth quarter. Jag Capital Management LLC now owns 11,401 shares of the medical research company’s stock worth $2,638,000 after acquiring an additional 49 shares during the period. Laurel Wealth Advisors LLC raised its holdings in shares of IQVIA by 1.1% during the third quarter. Laurel Wealth Advisors LLC now owns 4,710 shares of the medical research company’s stock worth $927,000 after acquiring an additional 50 shares during the period. Raleigh Capital Management Inc. raised its holdings in shares of IQVIA by 4.5% during the fourth quarter. Raleigh Capital Management Inc. now owns 1,157 shares of the medical research company’s stock worth $268,000 after acquiring an additional 50 shares during the period. Parkside Financial Bank & Trust raised its holdings in shares of IQVIA by 18.1% during the third quarter. Parkside Financial Bank & Trust now owns 346 shares of the medical research company’s stock worth $68,000 after acquiring an additional 53 shares during the period. Finally, B. Riley Wealth Advisors Inc. raised its holdings in shares of IQVIA by 1.6% during the third quarter. B. Riley Wealth Advisors Inc. now owns 3,568 shares of the medical research company’s stock worth $702,000 after acquiring an additional 56 shares during the period. Institutional investors own 89.62% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Leerink Partnrs reiterated an “outperform” rating on shares of IQVIA in a research note on Monday, February 26th. Truist Financial lowered their price target on shares of IQVIA from $297.00 to $292.00 and set a “buy” rating on the stock in a research note on Friday, May 3rd. SVB Leerink assumed coverage on shares of IQVIA in a research note on Monday, February 26th. They issued an “outperform” rating and a $290.00 price target on the stock. Robert W. Baird lowered their price target on shares of IQVIA from $254.00 to $245.00 and set a “neutral” rating on the stock in a research note on Friday, May 3rd. Finally, The Goldman Sachs Group initiated coverage on shares of IQVIA in a research note on Thursday, June 6th. They issued a “buy” rating and a $270.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $258.40.

IQVIA Stock Performance

Shares of IQV stock opened at $212.83 on Thursday. The company has a market capitalization of $38.78 billion, a price-to-earnings ratio of 29.08, a PEG ratio of 1.94 and a beta of 1.53. The company has a debt-to-equity ratio of 2.02, a quick ratio of 0.88 and a current ratio of 0.88. The company has a 50-day simple moving average of $226.40 and a 200 day simple moving average of $230.28. IQVIA Holdings Inc. has a 52 week low of $167.42 and a 52 week high of $261.73.

IQVIA (NYSE:IQV) last announced its earnings results on Thursday, May 2nd. The medical research company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.19 by $0.11. The business had revenue of $3.74 billion during the quarter, compared to the consensus estimate of $3.69 billion. IQVIA had a net margin of 9.01% and a return on equity of 29.17%. On average, sell-side analysts predict that IQVIA Holdings Inc. will post 10.11 earnings per share for the current year.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.